Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.
Wallenberg Centre for Molecular Medicine, Lund University, BMC A12, 221 84 Lund, Sweden.
Sci Immunol. 2022 Mar 4;7(69):eabg5539. doi: 10.1126/sciimmunol.abg5539.
Type 1 conventional dendritic cells (cDC1s) are rare immune cells critical for the induction of antigen-specific cytotoxic CD8 T cells, although the genetic program driving human cDC1 specification remains largely unexplored. We previously identified PU.1, IRF8, and BATF3 transcription factors as sufficient to induce cDC1 fate in mouse fibroblasts, but reprogramming of human somatic cells was limited by low efficiency. Here, we investigated single-cell transcriptional dynamics during human cDC1 reprogramming. Human induced cDC1s (hiDC1s) generated from embryonic fibroblasts gradually acquired a global cDC1 transcriptional profile and expressed antigen presentation signatures, whereas other DC subsets were not induced at the single-cell level during the reprogramming process. We extracted gene modules associated with successful reprogramming and identified inflammatory signaling and the cDC1-inducing transcription factor network as key drivers of the process. Combining IFN-γ, IFN-β, and TNF-α with constitutive expression of cDC1-inducing transcription factors led to improvement of reprogramming efficiency by 190-fold. hiDC1s engulfed dead cells, secreted inflammatory cytokines, and performed antigen cross-presentation, key cDC1 functions. This approach allowed efficient hiDC1 generation from adult fibroblasts and mesenchymal stromal cells. Mechanistically, PU.1 showed dominant and independent chromatin targeting at early phases of reprogramming, recruiting IRF8 and BATF3 to shared binding sites. The cooperative binding at open enhancers and promoters led to silencing of fibroblast genes and activation of a cDC1 program. These findings provide mechanistic insights into human cDC1 specification and reprogramming and represent a platform for generating patient-tailored cDC1s, a long-sought DC subset for vaccination strategies in cancer immunotherapy.
1 型传统树突状细胞(cDC1)是诱导抗原特异性细胞毒性 CD8 T 细胞的罕见免疫细胞,尽管驱动人类 cDC1 特化的遗传程序在很大程度上仍未得到探索。我们之前已经确定了 PU.1、IRF8 和 BATF3 转录因子足以在小鼠成纤维细胞中诱导 cDC1 命运,但人类体细胞的重编程效率较低。在这里,我们研究了人类 cDC1 重编程过程中的单细胞转录动态。从胚胎成纤维细胞中产生的人诱导性 cDC1(hiDC1)逐渐获得了全局 cDC1 转录谱,并表达了抗原呈递特征,而在重编程过程中,其他 DC 亚群在单细胞水平上并未被诱导。我们提取了与成功重编程相关的基因模块,并确定了炎症信号和诱导 cDC1 的转录因子网络是该过程的关键驱动因素。将 IFN-γ、IFN-β 和 TNF-α与诱导 cDC1 的转录因子的组成型表达相结合,可将重编程效率提高 190 倍。hiDC1 吞噬死亡细胞,分泌炎症细胞因子,并进行抗原交叉呈递,这是 cDC1 的关键功能。这种方法允许从成体成纤维细胞和间充质基质细胞中高效生成 hiDC1。从机制上讲,PU.1 在重编程的早期阶段表现出主导和独立的染色质靶向,将 IRF8 和 BATF3 募集到共享的结合位点。在开放增强子和启动子上的协同结合导致成纤维细胞基因沉默和 cDC1 程序的激活。这些发现为人类 cDC1 特化和重编程提供了机制见解,并代表了生成患者定制的 cDC1 的平台,这是癌症免疫治疗中疫苗策略中长期寻求的 DC 亚群。